BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24736829)

  • 1. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.
    Hundsberger T; Tonder M; Hottinger A; Brügge D; Roelcke U; Putora PM; Stupp R; Weller M
    J Neurooncol; 2014 Jun; 118(2):321-328. PubMed ID: 24736829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults.
    Reyes-Botero G; Laigle-Donadey F; Mokhtari K; Martin-Duverneuil N; Delattre JY
    J Neurooncol; 2014 Dec; 120(3):581-6. PubMed ID: 25139026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and management of brainstem gliomas in adults. A retrospective Italian study.
    Salmaggi A; Fariselli L; Milanesi I; Lamperti E; Silvani A; Bizzi A; Maccagnano E; Trevisan E; Laguzzi E; Rudà R; Boiardi A; Soffietti R;
    J Neurol; 2008 Feb; 255(2):171-7. PubMed ID: 18293027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of 104 histologically proven adult brainstem gliomas: clinical symptoms, therapeutic approaches and prognostic factors.
    Reithmeier T; Kuzeawu A; Hentschel B; Loeffler M; Trippel M; Nikkhah G
    BMC Cancer; 2014 Feb; 14():115. PubMed ID: 24555482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognostic factors of adult brainstem gliomas: A retrospective analysis of histologically-proven 40 cases.
    Li S; Zhao Y; Huang H
    Medicine (Baltimore); 2024 May; 103(18):e37910. PubMed ID: 38701282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
    Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
    J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem gliomas in adults: prognostic factors and classification.
    Guillamo JS; Monjour A; Taillandier L; Devaux B; Varlet P; Haie-Meder C; Defer GL; Maison P; Mazeron JJ; Cornu P; Delattre JY;
    Brain; 2001 Dec; 124(Pt 12):2528-39. PubMed ID: 11701605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of three-dimensional conformal radiotherapy combined with temozolomide in treatment of diffuse brainstem gliomas].
    Fang HH; Nie Q; Kang JB; Li FM; Cai CL
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):707-9. PubMed ID: 22340055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
    Steidl E; Filipski K; Zeiner PS; Wagner M; Fokas E; Forster MT; Ronellenfitsch MW; Divé I; Steinbach JP; Harter PN; Bähr O
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2373-2383. PubMed ID: 33538917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
    Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
    Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
    J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
    Badhe PB; Chauhan PP; Mehta NK
    Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
    Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
    J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
    Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
    Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
    Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
    J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience.
    Klimo P; Pai Panandiker AS; Thompson CJ; Boop FA; Qaddoumi I; Gajjar A; Armstrong GT; Ellison DW; Kun LE; Ogg RJ; Sanford RA
    J Neurosurg Pediatr; 2013 Mar; 11(3):274-81. PubMed ID: 23289916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas.
    Watkins JM; Marshall DT; Patel S; Giglio P; Herrin AE; Garrett-Mayer E; Jenrette JM
    J Neurooncol; 2009 Jul; 93(3):343-8. PubMed ID: 19142584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution.
    Céfaro GA; Genovesi D; Vinciguerra A; Trignani M; Taraborrelli M; Augurio A; Buonaguidi R; Galzio RJ; Di Nicola M
    Strahlenther Onkol; 2011 Dec; 187(12):778-83. PubMed ID: 22127356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.